Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
EXCLI Journal|July 16, 2021
Co-stimulatory agonists: An insight into the immunotherapy of cancerRamin Pourakbari, Farnaz Hajizadeh, Forough Parhizkar, et al.
Journal of Cellular Physiology|December 5, 2018
Immune checkpoint blockade opens a new way to cancer immunotherapySanam Sadreddini, Behzad Baradaran, Ali Aghebati-Maleki, et al.
Cell Communication and Signaling : CCS|November 10, 2023
Advances in immune checkpoint-based immunotherapies for multiple sclerosis: rationale and practiceAmin Daei Sorkhabi, Erfan Komijani, Aila Sarkesh, et al.
Regenerative Medicine|February 5, 2021
Platelet lysate: a promising candidate in regenerative medicineVafa Meftahpour, Somaiyeh Malekghasemi, Amir Baghbanzadeh, et al.
Multiple Sclerosis and Related Disorders|July 21, 2024
Altered gene expression of miR-155 in peripheral blood mononuclear cells of Multiple sclerosis patients: Correlation with TH17 frequency, inflammatory cytokine profile and autoimmunityShiva Alipour, Pedram Amanallahi, Behzad Baradaran, et al.
Journal of Cellular Physiology|June 5, 2019
Implications of exosomes as diagnostic and therapeutic strategies in cancerAli Aghebati-Maleki, Sanam Nami, Amir Baghbanzadeh, et al.
Neuroscience Letters|November 7, 2024
Altered miR-10a gene expression in peripheral blood mononuclear cells correlates with frequency of T regulatory cells and cytokine profile in multiple sclerosis patientsShiva Alipour, Ali Aghebati-Maleki, Mohammad Reza Sadeghi, et al.
Iranian Journal of Immunology : IJI|March 10, 2026
Investigating Autophagy Genes Expression and their Possible Relations with ‎Apoptosis in PBMCs of Patients with Thin EndometriumLida Aslanian-Kalkhoran, Mohammad Sadegh Soltani-Zangbar, Ali Aghebati-Maleki, et al.
Advanced Pharmaceutical Bulletin|December 7, 2013
Large Scale Generation and Characterization of Anti-Human CD34 Monoclonal Antibody in Ascetic Fluid of Balb/c MiceLeili Aghebati Maleki, Jafar Majidi, Behzad Baradaran, et al.
Human Immunology|March 28, 2025
Investigation of immune checkpoint molecules (CTLA-4, PD-1, PD-L1, Tim-3) expressions in preeclampsia: A comparative study of membranous and soluble formsForough Parhizkar, Najibeh Shekari, Zanyar HajiEsmailPoor, et al.
Pageof 4